Lysholm Department of Neuroradiology, National Hospital for Neurology & Neurosurgery, London, UK.
J Neurol Neurosurg Psychiatry. 2010 Dec;81(12):1383-9. doi: 10.1136/jnnp.2010.207993. Epub 2010 Sep 14.
There is substantial variability in the responsiveness of dystonia patients to deep brain stimulation (DBS), presumably due to the multiple causes of dystonia. This article presents the results of an analysis of the combined published results of individual patient outcomes following DBS for all types of dystonia. From 157 papers reporting clinical outcomes of DBS for dystonia, individual quantitative data were available for 466 patients with all forms of dystonia. The subclassification of these patients included 344 with primary forms of dystonia, 10 with myoclonus dystonia, 19 with heredodegenerative dystonias and 93 who had DBS for secondary dystonia. Patients with primary forms of dystonia, myoclonus dystonia, subtypes of heredo-degenerative dystonia and tardive dystonia have a greater than 50% mean improvement in dystonia severity following DBS. Among patients with primary generalised dystonia, multiple regression analysis showed that a shorter duration of symptoms (p=0.008), a lower baseline severity score (p=0.024) and DYT1 positive status (p=0.002) were all independently associated with a significantly higher percentage improvement from surgery. Patients with other forms of heredodegenerative and secondary dystonia have variable responses, making prediction of response in future patients difficult. The degree of dystonia response that justifies DBS is a highly subjective issue. Emphasis should be placed on both safety of surgical technique and an in-depth evaluation of patients' own perception of their life before and after DBS by using validated quality of life measures, in addition to existing use of objective severity scales.
在接受深部脑刺激 (DBS) 的肌张力障碍患者中,其反应性存在显著差异,这可能是由于肌张力障碍的多种病因所致。本文报告了对 DBS 治疗各种类型肌张力障碍的患者个体结局的综合已发表结果进行分析的结果。从 157 篇报告 DBS 治疗肌张力障碍的临床结局的论文中,有 466 名患者的个体定量数据可用于分析。这些患者的亚分类包括 344 名原发性肌张力障碍患者、10 名肌阵挛性肌张力障碍患者、19 名遗传性进行性肌张力障碍患者和 93 名继发性肌张力障碍患者接受 DBS 治疗。原发性肌张力障碍、肌阵挛性肌张力障碍、遗传性进行性肌张力障碍亚型和迟发性肌张力障碍患者在接受 DBS 后,肌张力障碍严重程度的平均改善程度大于 50%。在原发性全身性肌张力障碍患者中,多元回归分析显示,症状持续时间较短(p=0.008)、基线严重程度评分较低(p=0.024)和 DYT1 阳性状态(p=0.002)均与手术治疗后的改善百分比显著相关。其他形式的遗传性和继发性肌张力障碍患者的反应各不相同,因此难以预测未来患者的反应。 justifies DBS 的肌张力障碍反应程度是一个高度主观的问题。除了现有的客观严重程度量表外,还应强调手术技术的安全性以及使用经过验证的生活质量措施对患者自身在 DBS 前后生活的感知进行深入评估。